MétaCan
Menu
← Back to cohort
Record W4397041512 · doi:10.1681/asn.20233411s1581a

Incidence and Risk Factors for Obesity and Short Stature in Childhood Nephrotic Syndrome: A Prospective Cohort Study

2023· article· en· W4397041512 on OpenAlexaffabout
Cal Robinson, Nowrin F. Aman, Rahul Chanchlani, Vaneet Dhillon, Christoph Licht, Damien Noone, Rachel Pearl, Seetha Radhakrishnan, Chia Wei Teoh, Rulan S. Parekh

Bibliographic record

VenueJournal of the American Society of Nephrology · 2023
Typearticle
Languageen
FieldMedicine
TopicRenal Diseases and Glomerulopathies
Canadian institutionsWomen's College HospitalMcMaster Children's HospitalHospital for Sick Children
Fundersnot available
KeywordsMedicineShort statureNephrotic syndromeIncidence (geometry)PediatricsProspective cohort studyObesityCohortChildhood obesityCohort studyInternal medicineOverweight

Abstract

fetched live from OpenAlex

Background: Children with nephrotic syndrome are at risk of obesity and short stature from repeated steroid treatment. The incidence, timing, and risk factors for these outcomes remain uncertain. Methods: We evaluated longitudinal growth and obesity in children (1-18yr) enrolled in Insight into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics (INSIGHT). We included nephrotic syndrome cases diagnosed from 1996-2019 in Greater Toronto. Growth parameters were measured at annual clinic visits. Primary outcomes were de novo obesity (body mass index (BMI) Z-score ≥+2) and short stature (height Z-score ≤-2). We calculated hazard ratios (HR) using Cox proportional hazards models. Results: We included 531 children with nephrotic syndrome (24% frequently relapsing (FRNS) by 1-year). At their initial clinic visit (within 1-year of diagnosis), 23.5% of cases were obese, 51.8% were overweight (BMI Z-score ≥+1), and 4.9% had short stature. At the last clinic visit, the prevalence of obesity had decreased (17.3%) and short stature was unchanged (3.8%). During median 4.2-year follow-up, 69 (17.7%) children developed obesity and 16 (3.3%) developed short stature, among those without obesity or short stature initially. Total relapse count was a significant predictor for de novo obesity (adjusted HR 1.03, 95%CI 1.01-1.06, p=0.01) and short stature (unadjusted HR 1.06, 95%CI 1.02-1.10, p=0.01). Children with >6 and >12 total relapses were more likely to develop obesity and short stature, respectively. Conclusions: Obesity is common among children with nephrotic syndrome early after diagnosis, but prevalence decreases over time. Effective relapse prevention may reduce steroid exposure and the risks of de novo obesity or short stature. Funding: Government Support - Non-U.S. - Obesity and height outcomes, by FRNS classification within 1-year of diagnosis Outcome Overall (n=531) Non FRNS (n=404) FRNS (n=127) Prevalent obesity at initial clinic visit, n (%) 125/531 (23.5) 89/404 (22.0) 36/127 (28.4) De novo obesity during follow-up, n (%) 69/390 (17.7) 46/302 (15.2) 23/88 (26.1) Prevalent obesity at last clinic visit, n (%) 91/526 (17.3) 65/399 (16.3) 26/127 (20.5) Prevalent short stature at initial clinic visit, n (%) 26/531 (4.9) 21/404 (5.2) 5/127 (3.9) De novo short stature during follow-up, n (%) 16/488 (3.3) 8/369 (2.2) 8/119 (6.7) Prevalent short stature at last clinic visit, n (%) 20/525 (3.8) 13/398 (3.3) 7/127 (5.5) Change in BMI Z-score during follow-up, mean (SD) -0.52 (1.23) -0.48 (1.19) -0.65 (1.34) Change in height Z-score during follow-up, mean (SD) +0.19 (0.84) +0.22 (0.79) +0.09 (0.97)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.055

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.274
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicRenal Diseases and Glomerulopathies→French-language works237,207→